Impact of COVID‑19 infection on subsequent prescriptions of autonomic dysfunction pharmacotherapy: a nationwide propensity‑score‑matched Cohort study in Japan
COVID-19 infection is significantly associated with increased initiation of pharmacotherapy for autonomic dysfunction, with sustained risk beyond one year. These findings highlight the to manage autonomic dysfunction among COVID-19 survivors and informing clinical care and public health planning.
Authors
- Masanori Ito
- Daisuke Miyamori (ORCID: https://orcid.org/0000-0002-1352-3738)
Institutions
- Hiroshima University Hospital (JP)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2026-01-20
- DOI
- https://doi.org/10.1080/07853890.2026.2618323
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 0.00